Adam Le
The US pension giant has come up with a pricing strategy that could make it benefit more from this portfolio sale, Secondaries Investor understands.
The firm has its eye on programmatic sellers with its $30bn latest raise for ASF IX.
Ardian’s $30bn haul and Evercore’s estimate of $160bn in deal volume suggest the next phase of the market’s development has begun.
Rob Campbell, head of North America at ICG's Strategic Equity unit, outlines elements for a successful CV when just one asset is involved and why such deals differ from co-investments.
Human resources is one of the biggest issues restricting the growth of the secondaries market, sources have long told Secondaries Investor.
Can you remember the most unexpected departures and appointments of the last 12 months?
Our most popular podcast episodes this year include a deep dive into the origins of zombie funds and CVs, and a 360-degree discussion on what it means to be a lead investor.
The $1.2bn secondaries transaction involves R1 RCM, a healthcare sector revenue cycle management services provider.
Fundraising, deal volume, new entrants and people news piqued readers’ attention in what was another dramatic year for the secondaries market.
The firm has temporarily delayed capital raising for GP Equity Solutions and is instead focusing on dealmaking, Secondaries Investor has learned.









